Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Hyperfine, Inc. (HYPR : NSDQ)
 
 • Company Description   
Hyperfine Inc. is a groundbreaking medical device company which created Swoop(R), first FDA-cleared portable MRI system(TM). Hyperfine Inc., formerly known as HealthCor Catalio Acquisition Corp., is based in GUILFORD, Conn.

Number of Employees: 193

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.88 Daily Weekly Monthly
20 Day Moving Average: 155,992 shares
Shares Outstanding: 70.33 (millions)
Market Capitalization: $202.56 (millions)
Beta: 0.82
52 Week High: $16.61
52 Week Low: $2.00
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -24.21% -17.29%
12 Week -16.76% -12.37%
Year To Date -60.28% -53.69%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
351 NEW WHITFIELD STREET
-
GUILFORD,CT 06437
USA
ph: 203-458-7100
fax: -
investors@hyperfine.io https://hyperfine.io
 
 • General Corporate Information   
Officers
Dave Scott - Chief Executive Officer; President and Director
R. Scott Huennekens - Executive Chairman of the Board
John Dahldorf - Vice Chairman of the Board
Alok Gupta - Chief Financial Officer
Ruth Fattori - Director

Peer Information
Hyperfine, Inc. (ABMD)
Hyperfine, Inc. (DMDS)
Hyperfine, Inc. (CPWY.)
Hyperfine, Inc. (EQUR)
Hyperfine, Inc. (ECIA)
Hyperfine, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 44916K106
SIC: 3845
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/10/22
Share - Related Items
Shares Outstanding: 70.33
Most Recent Split Date: (:1)
Beta: 0.82
Market Capitalization: $202.56 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/10/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 1.22
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 87.55%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: 246.10%
ROE
03/31/22 - -59.73
12/31/21 - -60.78
09/30/21 - -
ROA
03/31/22 - -26.18
12/31/21 - -13.81
09/30/21 - -
Current Ratio
03/31/22 - 15.22
12/31/21 - 12.55
09/30/21 - 0.48
Quick Ratio
03/31/22 - 14.82
12/31/21 - 12.28
09/30/21 - 0.48
Operating Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Net Margin
03/31/22 - -
12/31/21 - -
09/30/21 - -
Pre-Tax Margin
03/31/22 - -4,155.89
12/31/21 - -4,334.96
09/30/21 - -
Book Value
03/31/22 - 2.37
12/31/21 - 2.65
09/30/21 - -0.39
Inventory Turnover
03/31/22 - 1.57
12/31/21 - 2.47
09/30/21 - -
Debt-to-Equity
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - -
Debt-to-Capital
03/31/22 - 0.00
12/31/21 - 0.00
09/30/21 - -
 

Powered by Zacks Investment Research ©